Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (14266)	7/30/2000 11:35:21 PM
From: aknahow	Read Replies (1) \| Respond to of 17367

The call is scheduled for Aug. 14. It will be the first time a full quarter does not include any Neuprex expenses. I agree with you that news that has occurred can't be held back. But while this applies IMO absolutely to bad news, sometimes good news can be scheduled. When does one actually sign an agreement? Do you think it is impossible to schedule the signing to occur just prior to a conference call? While I don't believe there will be any big news either, I do believe if there was something like an agreement for Mycoprex or Genimune that no news would be deemed to have occurred until an agreement was actually signed and that signing can be scheduled within reason.